How to read: Every bubble is one Indian piperacillin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Piperacillin report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial piperacillin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian piperacillin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Piperacillin India trade report
P
Product scope
Piperacillin
All variants merged — branded and generic formulations of piperacillin
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
138
Every commercial piperacillin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a v-curve: Oct $773.9K, Nov $655.9K, Dec $1.1M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$773.9K
Oct USD
21 shipments
2
$655.9K
Nov USD
-15.3% MoM
3
$1.1M
Dec USD
+67.5% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 15.3% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $774K, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: EUGIA PHARMA SPECIALITIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import piperacillin from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited States absorbs 24.5% of India’s 2025-Q4 piperacillin trade ($619.9K). Beyond the top 10 destinations, 45 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 14 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 45 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much piperacillin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$915K
36.2% of trade
14 countries · 59 shipments
Europe
$384K
15.2% of trade
5 countries · 11 shipments
Americas
$1.1M
42.3% of trade
13 countries · 29 shipments
Africa
$161K
6.4% of trade
12 countries · 38 shipments
Oceania
$153
0.0% of trade
1 countries · 1 shipments
Fig 4.1 United States is the #1 corridor ($620K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian piperacillin it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United States
$620K
9
EUGIA PHARMA SPECIALITIES LTD
$620K
—
—
—
—
2
Philippines
$503K
30
UNOSOURCE PHARMA LTD
$156K
UNI MEDICOLABS
$154K
STALLION LABORATORIES PVT LTD
$85K
3
Brazil
$334K
6
ONESOURCE SPECIALTY PHARMA LTD
$334K
—
—
—
—
4
United Kingdom
$248K
2
EUGIA PHARMA SPECIALITIES LTD
$248K
—
—
—
—
5
Yemen
$181K
1
CIPLA LTD
$181K
—
—
—
—
6
France
$105K
6
GALPHA LABORATORIES LTD
$62K
IMPACT HEALTHCARE PVT LTD
$18K
GEPACH INTERNATIONAL
$18K
7
Kenya
$92K
6
ALKEM LABORATORIES LTD
$33K
UNOSOURCE PHARMA LTD
$32K
SWISS PARENTERALS LTD
$19K
8
Azerbaijan
$89K
4
ALCHEMY MEDICINE PVT LTD
$89K
—
—
—
—
9
Nepal
$67K
6
ALKEM LABORATORIES LTD
$65K
MICRO LABS LTD
$2K
—
—
10
Panama
$44K
1
SAKAR HEALTHCARE LTD
$44K
—
—
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 36.2% of USD — but United States is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
24.5%
#1 country share
United States alone
74.6%
Top 5 share
5 of 45 countries
95.3%
Top 15 share
Long tail of 30 countries = 4.7%
HHI 1379
Destination HHI
Competitive spread
45
Countries served
Global pharma reach from India
14
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
55 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYEUGIA PHARMA SPECIALITIES LTD ($867.6K, 34.3% share) and ONESOURCE SPECIALTY PHARMA LTD ($334.8K) together control 47.6% of India’s 2025-Q4 piperacillin trade. The top 5 suppliers hold 68.3%. 55 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian piperacillin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 EUGIA PHARMA SPECIALITIES LTD leads by $533K over ONESOURCE SPECIALTY PHARMA LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: CIPLA LTD is #4 by value but #15 by volume.
Fig 5.2 EUGIA PHARMA SPECIALITIES LTD also leads by shipment count (11) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: CIPLA LTD moves from #15 by volume to #4 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 55 piperacillin suppliers split into strategic segments
KEY TAKEAWAY14 suppliers (25%) generate 91.2% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 EUGIA PHARMA SPECIALITIES LTD and ONESOURCE SPECIALTY PHARMA LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 91.2% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
47 importers across 45 countries — who is buying Indian piperacillin and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 87.9% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian piperacillin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 EUGIA US LLC is the #1 importer at $620K (24.5%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian piperacillin prices vary by supplier, country and dosage form
KEY TAKEAWAYPiperacillin prices span 83319× ($0.0009 → $78.05). The coefficient of variation is 2.80. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. EUGIA PHARMA SPECIALITIESSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ONESOURCE SPECIALTY PHARMASourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. SAKAR HEALTHCARE LTDSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. CIPLA LTDSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
D VIJAY PHARMA P…
Dominica
Injection
5
$1K
$263.67
Sterile formulation premium
Dec 2025
SYNMEX PHARMA PV…
DR Congo
Injection
50
$4K
$78.05
Sterile formulation premium
Dec 2025
SYNMEX PHARMA PV…
DR Congo
Injection
1
$54.63
$54.63
Sterile formulation premium
Dec 2025
ONESOURCE SPECIA…
Brazil
Injection
2K
$28K
$16.50
Sterile formulation premium
Dec 2025
ONESOURCE SPECIA…
Brazil
Injection
4K
$67K
$16.50
Sterile formulation premium
Dec 2025
ONESOURCE SPECIA…
Brazil
Injection
4K
$69K
$16.50
Sterile formulation premium
Dec 2025
ONESOURCE SPECIA…
Brazil
Injection
4K
$69K
$16.50
Sterile formulation premium
Dec 2025
ONESOURCE SPECIA…
Brazil
Injection
4K
$68K
$16.50
Sterile formulation premium
Dec 2025
ONESOURCE SPECIA…
Brazil
Injection
2K
$33K
$16.50
Sterile formulation premium
Nov 2025
NARAYANA HRUDAYA…
Cayman Islands
Injection
300
$2K
$8.09
Sterile formulation premium
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
BURHANI GLOBEX
Somalia
Injection
5K
$32.80
$0.0066
Sterile formulation premium
Dec 2025
BURHANI GLOBEX
Somalia
Injection
35
$0.230
$0.0066
Sterile formulation premium
Dec 2025
ALKEM LABORATORI…
Tanzania
Injection
29K
$227.90
$0.0078
Sterile formulation premium
Dec 2025
MDS ENTERPRISES
United Arab Emirates
Injection
500
$5.13
$0.010
Sterile formulation premium
Dec 2025
EAST AFRICAN IND…
Mauritius
Injection
3K
$54.01
$0.020
Sterile formulation premium
Dec 2025
GEPACH INTERNATI…
France
Injection
6K
$225.59
$0.041
Sterile formulation premium
Nov 2025
VIDA LABORATORIE…
Honduras
Injection
100
$8.48
$0.085
Sterile formulation premium
Dec 2025
ONESOURCE SPECIA…
Malaysia
Injection
4K
$772.19
$0.188
Sterile formulation premium
Nov 2025
SHALINA LABORATO…
South Sudan
Injection
100K
$19K
$0.193
Sterile formulation premium
Nov 2025
ALKEM LABORATORI…
Nepal
Injection
40K
$11K
$0.277
Sterile formulation premium
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship piperacillin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYPiperacillin leaves India through 14+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), HYDERABAD AIR, HYDERABAD ICD) handle 82.3% of total USD. ICD moves 18% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $598K — top 14 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYICD dominates at 18% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
ICD
$943K
37.3% of USD · 18.1% of ships
AIR
$920K
36.4% of USD · 52.9% of ships
SEA
$598K
23.7% of USD · 24.6% of ships
ROAD
$67K
2.6% of USD · 4.3% of ships
Fig 8.3 The dominant corridor is HYDERABAD AIR → Air → N. America ($464K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYUnited States is the most concentrated destination (HHI 10000, 1 suppliers). Philippines is the most competitive (HHI 2447).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United States (HHI 10,000) is the most concentrated — Philippines (HHI 2,447) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 19 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
EUGIA US LLC
United States
EUGIA PHARMA SPE…
$620K
9
CRITICAL
VIATRIS BRASIL IMPOR…
Brazil
ONESOURCE SPECIA…
$334K
6
HIGH
MILPHARM LTD
United Kingdom
EUGIA PHARMA SPE…
$248K
2
HIGH
AL JABAL DRUGS & MED…
Yemen
CIPLA LTD
$181K
1
HIGH
AMBICA INTERNATIONAL…
Philippines
UNOSOURCE PHARMA…
$156K
7
HIGH
GREENCORE PHARMA INC
Philippines
UNI MEDICOLABS
$154K
6
HIGH
REFERANS PHARMACEUTI…
Azerbaijan
ALCHEMY MEDICINE…
$89K
4
MEDIUM
PARTH PHARMA DISTRIB…
Nepal
ALKEM LABORATORI…
$65K
5
MEDIUM
Conclusion: 43 buyers depend on exactly one Indian supplier, representing $2.2M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
PLANET PHARMA SA
France
3
$56K
GALPHA LABORAT…
MEDIUM
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United States
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Philippines
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Brazil
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
United Kingdom
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Yemen
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Azerbaijan
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Nepal
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Panama
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Nicaragua
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Lebanon
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Dominican Republic
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Tanzania
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Greece
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 1 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Philippines are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in United States
This Q
HIGH
A2
Offer alternative to PLANET PHARMA
This Q
HIGH
A3
Audit United States lock-ins (HHI 10000)
This Q
MED
A5
Enter Philippines (5 suppliers)
This Q
HIGH
A6
Enter United States (1 suppliers)
This Q
MED
A8
Build Philippines distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for United States tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Philippines
Asia
5
$503K
+479.7%
LOW
Growing 480% with only 5 competitors
2
United States
Other
1
$620K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Brazil
Other
1
$334K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
4
United Kingdom
Other
1
$248K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Yemen
Other
1
$181K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
France
Other
4
$105K
-13%
LOW
Low competition (4 suppliers), accessible market
7
Kenya
Africa
4
$92K
-100%
LOW
Low competition (4 suppliers), accessible market
8
Azerbaijan
Other
1
$89K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Nepal
Asia
2
$67K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
10
Panama
Other
1
$44K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Nicaragua
Other
1
$36K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Lebanon
Other
1
$28K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Dominican Republic
Other
1
$23K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Tanzania
Africa
2
$20K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
15
Greece
Other
1
$20K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 138 2025-Q4 Piperacillin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/piperacillin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 138 2025-Q4 piperacillin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian piperacillin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
138
across all regions
TOTAL USD
$2.53M
2025-Q4 FOB value
UNITS
1.8M
tablets, capsules, etc.
SUPPLIERS
55
Indian exporters
BUYERS
47
global importers
COUNTRIES
45
destinations
§10.2 Regional breakdown
Africa
$161K
6.4%
12 ctry · 38 ships
Asia
$915K
36.2%
14 ctry · 59 ships
Europe
$384K
15.2%
5 ctry · 11 ships
Americas
$1.07M
42.3%
13 ctry · 29 ships
Oceania
$152.99
0.0%
1 ctry · 1 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $161K (6.4%), spanning 12 countries.
🏢
55 Indian suppliers shipped to 47 buyers across 45 countries — average shipment value $18K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 45 global piperacillin importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian piperacillin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
EUGIA US LLC
United States
9
$620K
EUGIA PHARMA SPECIAL…
Injection
2
VIATRIS BRASIL IMPORTADORA E DISTRI
Brazil
6
$334K
ONESOURCE SPECIALTY …
Injection
3
MILPHARM LTD
United Kingdom
2
$248K
EUGIA PHARMA SPECIAL…
Injection
4
AL JABAL DRUGS & MEDICAL APPLIANCES
Yemen
1
$181K
CIPLA LTD
Injection
5
AMBICA INTERNATIONAL CORP
Philippines
7
$156K
UNOSOURCE PHARMA LTD
Injection
6
GREENCORE PHARMA INC
Philippines
6
$154K
UNI MEDICOLABS
Injection, injectio
7
REFERANS PHARMACEUTICALS PVT LTD
Azerbaijan
4
$89K
ALCHEMY MEDICINE PVT…
Injection
8
PARTH PHARMA DISTRIBUTORS PVT LTD
Nepal
5
$65K
ALKEM LABORATORIES LTD
Injection
9
PLANET PHARMA SA
France
4
$56K
GALPHA LABORATORIES …
Tablet, Injection
10
VESALIUS PHARMA SA
Panama
1
$44K
SAKAR HEALTHCARE LTD
Injection
11
CORPORACION CEFA DE NICARAGUA, S.A
Nicaragua
1
$36K
ACULIFE HEALTHCARE P…
Injection
12
IE MEDICA INC
Philippines
2
$36K
STRATGEN HEALTHCARE …
13
PHARMACOR LTD
Kenya
2
$33K
ALKEM LABORATORIES LTD
Injection, Vial
14
IMAGINE PHARMACEUTICALS LTD
Kenya
1
$32K
UNOSOURCE PHARMA LTD
Injection
15
PLANET PHARMAZONE DACTIVITE DU GRA
France
1
$31K
GALPHA LABORATORIES …
Injection
16
TO PARTY PLANET PHARMACEUTICAL LTD
Tanzania
2
$20K
ARISTO PHARMACEUTICA…
Injection
17
SHALINA PHARMACY LTD
South Sudan
1
$19K
SHALINA LABORATORIES…
Injection
18
PIEX SOCIETE PHARMACEUTIQUE
France
1
$18K
IMPACT HEALTHCARE PV…
Injection
19
SAK CAM PHARMA CO LTD
Cambodia
2
$14K
UNITED BIOTECH PVT LTD
Injection
20
ENTO LLC
Mongolia
1
$10K
PROCARE PHARMA PVT LTD
Injection
21
WESSEX PHARMACEUTICALS LTD
Kenya
1
$8K
ZEISS PHARMACEUTICAL…
22
RAOUFI GLOBAL GROUP COMPANY
Afghanistan
2
$6K
ZYDUS LIFESCIENCES LTD
Injection
23
MEDICO PLUS
DR Congo
2
$4K
SYNMEX PHARMA PVT LTD
Injection
24
OVEROL INTERNACIONAL C.A
Venezuela
2
$4K
KWALITY PHARMACEUTIC…
Injection
25
ARK OF GLO NIG LTD
Nigeria
2
$3K
ETHER PHARMACEUTICAL…
Injection
26
HEALTH CITY CAYMAN ISLANDS (HCCI)
Cayman Islands
1
$2K
NARAYANA HRUDAYALAYA…
Injection
27
GREAT GRACE NIG LTD
Nigeria
1
$2K
ACIES PHARMACEUTICAL…
28
RAHUL PHARMA
Nepal
1
$2K
MICRO LABS LTD
Tablet
29
LUSAKA PHARMACEUTICALS LTD
Zambia
1
$2K
PATSONS INTERNATIONAL
Injection
30
LEVANT
Turkey
1
$1K
AMARI TRADE ALLIANCE…
Injection
31
ALIYAH SHILLINGFORD
Dominica
1
$1K
D VIJAY PHARMA PVT LTD
Injection
32
COMVIA HEALTH SOLUTIONS
Benin
2
$1K
IMPACT HEALTHCARE PV…
Injection
33
GLOBAL PHARMA SARL
Central African Republic
2
$959.29
IMPACT HEALTHCARE PV…
Injection
34
ZMC EXPRESS CARGO FZCO
United Arab Emirates
4
$938.05
SEATRACK INTERNATION…
Injection
35
UNIMED SDN BHD
Malaysia
1
$772.19
ONESOURCE SPECIALTY …
Injection
36
HORIZON PHARMACEUTICAL COMPANY
Somalia
1
$429.18
KHATU ENTERPRISES
Injection
37
ALLIANCE PHARMA SARL
Guinea-Bissau
1
$398.41
TRIDENT IMPEX
38
SONIA FARMACIA SARL
Guinea-Bissau
1
$359.40
BAKER & DAVIS PVT LTD
Injection
39
PLANET PHARMACEUTICAL LTD
Tanzania
1
$227.90
ALKEM LABORATORIES LTD
Injection
40
MR SHALVIN KUMAR
Fiji
1
$152.99
RUN MEDWAY
Injection
41
CARIMED TRADING
Saint Lucia
1
$77.83
SARA TRADING CORP
Injection
42
RAPATI ENTERPRISES
Singapore
1
$71.00
BAKER & DAVIS PVT LTD
Injection
43
SCOTT HEALTH LTD
Mauritius
1
$54.01
EAST AFRICAN INDIA O…
Injection
44
HC PHARMA HONDURAS S DE RL
Honduras
1
$8.48
VIDA LABORATORIES PV…
Injection
45
KEURO LIFE SCIENEC COMPANY
Saudi Arabia
1
$2.97
STERISCIENCE SPECIAL…
Other
This report covers 138 2025-Q4 Piperacillin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/piperacillin
Talk to our trade analyst
Need a custom piperacillin report or a deeper dive into any market? Our team is ready.